HOME >> BIOLOGY >> NEWS
Columbia Researchers Synthesize Compound With Possible Link To MacularDegeneration; Work Is Critical To Pinpointing Causes Of Disease, Scientists Say

Researchers at Columbia University have synthesized large quantities of a derivative of vitamin A that accumulates with age in human eyes and may contribute to the onset of age-related macular degeneration.

The Columbia team also was able to isolate and quantify compounds from individual donor eyes, including the vitamin A derivative, called A2E. Quantification of A2E in human cells could allow for a direct correlation of the amount of this material with macular degeneration. The work appears in the Dec. 8 issue of the Proceedings of the National Academy of Sciences.

The new synthesis is critical to biological and chemical experiments needed to pinpoint the relationship between A2E and age-related changes in the retina, the scientists say. The synthesis uses simple starting materials and can provide a 50 percent yield of A2E, an enormous increase over previous methods. Now, laboratories at Columbia and elsewhere will be able to make enough of the compound to forge ahead in the quest to understand the disease. The Columbia team already has developed several hypotheses describing the role of A2E in macular degeneration and is proceeding with experiments to refine their understanding.

"Although we are not certain that A2E is implicated in macular degeneration, it is certainly a leading candidate," said Craig Parish, a postdoctoral chemistry researcher at Columbia and first author of the work. Other collaborators, all at Columbia, were Masaru Hashimoto, postdoctoral chemistry researcher; Koji Nakanishi, Centennial Professor of Chemistry, and Janet Sparrow and James Dillon, associate professors of ophthalmology at Columbia's College of Physicians & Surgeons.

Age-related macular degeneration, or AMD, is believed to cause severe visual impairment or blindness in approximately 1.7 million of the 34 million Americans over the age of 65 and is the leading cause of blindness in that age group, according to the Nati
'"/>

Contact: Bob Nelson
rjn2@columbia.edu
212-854-6580
Columbia University
7-Dec-1998


Page: 1 2 3 4

Related biology news :

1. Columbia research to examine gene influence on severity of peridontal disease, therapy response
2. Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies
3. Worlds largest scientific society holds regional meeting in Columbia, Mo.
4. New Columbia Genomic Center of Excellence aims to speed genetic targeting of medicines
5. Columbia offers new ecology program in Dominican Republic
6. Columbia professor receives 2003 National Golden Apple for Teaching Excellence
7. Columbia investigators win 2003 Gairdner International Award for research
8. Gene newly identified by Columbia researchers may improve hair removal
9. Years of research, thought lead geologist to propose new supercontinent Columbia
10. Columbia team finds treatment that corrects cellular defect at the root of heart failure
11. ESA Corporate Award winner 2001: Weyerhaeuser Company Limited British Columbia Coastal Forest Project Team

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... SAN FRANCISCO (PRWEB) , ... December 04, 2018 ... ... for life sciences and diagnostics companies, announces the placement of Michael Mercer at ... the commercial business strategy, Mr. Mercer will be based at Karius' headquarters in ...
(Date:11/29/2018)... ... 29, 2018 , ... ACEA Biosciences , now a ... Research Center for Cell Manufacturing Technologies (CMaT). CMaT is a consortium ... technologies for the consistent, scalable and low-cost production of high-quality living therapeutic cells. ...
(Date:11/27/2018)... ... November 27, 2018 , ... Victrex has designed a new ... broader range of usage temperature compared to existing polymers such as PCTFE. At ... CTâ„¢ 200 for dynamic sealing applications where gases such as LNG* are stored ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... company backed by Siemens Healthineers and several healthcare VC firms announces at Distributed ... and making a history by purchasing tokens and obtaining its first radiology interpretations, ...
(Date:11/5/2018)... ... 2018 , ... 2Blades has completed a non-exclusive license agreement ... technology for applications in advancing research in epigenetic technology. , 2Blades holds ... 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in ...
(Date:11/3/2018)... DURHAM, N.C. (PRWEB) , ... November 01, 2018 , ... ... recognized by Inc. Magazine as one of the fastest-growing private companies in the United ... the Inc. 5000 list ranks private companies based on percentage revenue growth over the ...
(Date:10/31/2018)... ... October 30, 2018 , ... Myoscience, Inc. announced ... Campbell Clinic in Memphis, Tennessee. This study enrolled 125 patients and compares ... for managing pain after total knee replacement surgery (TKA). , The Myoscience iovera° ...
Breaking Biology Technology:
Cached News: